Israel Acquisitions CORP 8-K Filing
Ticker: ISLWF · Form: 8-K · Filed: Dec 2, 2025 · CIK: 1915328
Sentiment: neutral
Filing Stats: 1,747 words · 7 min read · ~6 pages · Grade level 16.9 · Accepted 2025-12-02 17:20:28
Key Financial Figures
- $0.0001 — LC Class A ordinary shares, par value $0.0001 per share ISRL The Nasdaq Stock Mar
- $11.50 — ary share, each at an exercise price of $11.50 per share ISRLW The Nasdaq Stock Ma
- $50 million — value of listed securities of at least $50 million (the " MVLS Requirement "). In accordan
Filing Documents
- tm2532580d1_8k.htm (8-K) — 38KB
- 0001104659-25-117788.txt ( ) — 258KB
- isrl-20251125.xsd (EX-101.SCH) — 4KB
- isrl-20251125_def.xml (EX-101.DEF) — 27KB
- isrl-20251125_lab.xml (EX-101.LAB) — 36KB
- isrl-20251125_pre.xml (EX-101.PRE) — 25KB
- tm2532580d1_8k_htm.xml (XML) — 7KB
Forward Looking Statements
Forward Looking Statements This communication contains "forward-looking statements," within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking "expects," "plans," "anticipates," "could," "intends," "projects," "contemplates," "predicts," "continue," "potential" or the negative of these terms or other similar words or expressions that predict or indicate future events or trends that are not statements of historical matters. These and projections about future events and financial trends as well as the beliefs and assumptions of management. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond each of the Company's and Gadfin's control. Actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: (i) the expected filing of the Form 25-NSE by Nasdaq; (ii) the Company's expectations that its securities will be eligible to trade on the OTC Markets, and the Company's expectations regarding the impact of its securities trading on the OTC Markets; (iii) the Company's ability to have the combined company's securities listed on Nasdaq following the Business Combination; (iv) risks associated with the timing of the closing of the proposed transaction, including the risks that a condition to closing would not be satisfied or waived within the expected timeframe or at all or that the closing of the proposed transactions will not occur; (v) the outcome of any legal proceedings that may be instituted against the parties and others related to the proposed transactions; and (vi) the occu